The next “Living Well with Myeloma” Teleconference will focus on approaches to relapsed myeloma. IMF Chairman of the Board Dr. Brian G.M. Durie will discuss:
- what treatments you should consider if your myeloma has relapsed, with a focus on the latest FDA-approved drugs.
- how to individualize treatment based on a patient’s prior therapies, the length of the onset of relapse, FiSH genetic-risk status, age, and frailty score.
- the latest clinical trials, in particular immune therapies.
You won’t want to miss this FREE IMF teleconference followed by a Q&A session! Save the date and register now!
We thank our sponsors for supporting this educational program:
Celgene, and Takeda Oncology